Ronald A. Asherson

Ronald A. Asherson's AcademicInfluence.com Rankings

Ronald A. Asherson

Philosophy

#6914

World Rank

#10037

Historical Rank

Logic

#4002

World Rank

#5242

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Ronald A. Asherson Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ronald A. Asherson's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The “Primary” Antiphospholipid Syndrome: Major Clinical and Serological Features (1989) (998)
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines (2003) (743)
Anticardiolipin antibodies: isotype distribution and phospholipid specificity. (1987) (679)
Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. (1986) (569)
Catastrophic Antiphospholipid Syndrome: Clinical and Laboratory Features of 50 Patients (1998) (514)
Catastrophic Antiphospholipid Syndrome: Clues to the Pathogenesis from a Series of 80 Patients (2001) (404)
Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. (1989) (328)
Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus (1990) (309)
Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients. (2006) (293)
Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody (1985) (289)
Chorea in the Antiphospholipid Syndrome: Clinical, Radiologic, and Immunologic Characteristics of 50 Patients from Our Clinics and the Recent Literature (1997) (243)
Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. (1990) (227)
Antiphospholipid antibodies and infections (2003) (227)
Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome (2005) (225)
Anticardiolipin antibodies in autoimmune thrombocytopenic purpura (1985) (223)
Cerebral infarction in systemic lupus: association with anticardiolipin antibodies. (1984) (196)
Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients (2004) (187)
Adrenal Involvement in the Antiphospholipid Syndrome: Clinical and Immunologic Characteristics of 86 Patients (2003) (185)
Catastrophic antiphospholipid syndrome. (2016) (167)
Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies. (1987) (162)
Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the 'primary' antiphospholipid syndrome. (1989) (154)
Chorea in systemic lupus erythematosus and "lupus-like" disease: association with antiphospholipid antibodies. (1987) (148)
Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies (2004) (147)
The lung in the antiphospholipid syndrome (2002) (146)
Antiphospholipid Syndrome Infectious Origin (2004) (145)
Anticardiolipin antibodies: occurrence in Behçet's syndrome. (1984) (141)
Long term outcome of catastrophic antiphospholipid syndrome survivors (2003) (136)
Anticardiolipin antibodies--clinical associations. (1986) (136)
Cardiac manifestations of the antiphospholipid syndrome. (1993) (133)
Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. (1993) (132)
Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal. (1985) (128)
Antiphospholipid Anti-Bodies—Autoantibodies with a Difference (1988) (127)
Primary antiphospholipid syndrome (1988) (127)
High Prevalence of Significant Heart Valve Lesions in Patients with the 'Primary' Antiphospholipid Syndrome (1991) (127)
Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients. (2006) (123)
The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus. (2007) (118)
'Primary', 'Secondary' and Other Variants of the Antiphospholipid Syndrome (1994) (114)
The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome--molecular mimicry? (2000) (108)
Catastrophic antiphospholipid syndrome: where do we stand? (2003) (106)
41 – THE CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME (2004) (106)
Review: antiphospholipid antibodies and the lung. (1995) (103)
Pulmonary hypertension in systemic lupus erythematosus. (1983) (100)
Anticardiolipin, anti-β2-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease (2003) (99)
Antiphospholipid syndrome: five year follow up. (1991) (97)
Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases (2007) (92)
Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients (2005) (89)
Major histocompatibility complex associations with primary antiphospholipid syndrome. (1992) (88)
Multiorgan failure and antiphospholipid antibodies: the catastrophic antiphospholipid (Asherson's) syndrome. (2005) (85)
Large vessel occlusion and gangrene in systemic lupus erythematosus and "lupus-like" disease. A report of six cases. (1986) (85)
Myocardial infarction and antiphospholipid antibodies in SLE and related disorders. (1989) (82)
Catastrophic antiphospholipid syndrome (2000) (81)
Antiphospholipid antibodies and the heart. Lessons and pitfalls for the cardiologist. (1991) (78)
Catastrophic antiphospholipid syndrome: response to repeated plasmapheresis over three years. (1997) (78)
The spectrum of livedo reticularis and anticardiolipin antibodies (1989) (78)
The antiphospholipid syndrome: a syndrome in evolution. (1992) (78)
New subsets of the antiphospholipid syndrome in 2006: "PRE-APS" (probable APS) and microangiopathic antiphospholipid syndromes ("MAPS"). (2006) (77)
Cerebral and valve lesions in SLE: association with antiphospholipid antibodies. (1988) (76)
The antiphospholipid syndrome II : autoimmune thrombosis (2002) (76)
Treatment of catastrophic antiphospholipid syndrome with defibrotide, a proposed vascular endothelial cell modulator. (2002) (75)
The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients (2005) (74)
Relapsing catastrophic antiphospholipid syndrome: report of three cases. (2008) (74)
The antiphospholipid antibody syndrome: diagnosis, skin manifestations and current therapy. (2006) (74)
Catastrophic antiphospholipid syndrome and sepsis. A common link? (2007) (73)
Unusual manifestations of the antiphospholipid syndrome (2003) (72)
Antiphospholipid syndrome induced by HIV (2001) (71)
Autoantibodies in Nonautoimmune Individuals during Infections (2007) (71)
Antiendothelial cell antibodies in patients with the antiphospholipid syndrome. (1991) (71)
Recurrent deep vein thrombosis and Addison's disease in "primary" antiphospholipid syndrome. (1989) (70)
Microvascular and microangiopathic antiphospholipid-associated syndromes ("MAPS"): semantic or antisemantic? (2008) (68)
Hypoadrenalism, Addison's disease and antiphospholipid antibodies. (1991) (68)
Adult-onset polymyositis-dermatomyositis: description of 25 patients with emphasis on treatment. (1990) (65)
A prospective evaluation of antithyroid antibody prevalence in 100 patients with systemic lupus erythematosus. (1991) (64)
Clinical and epidemiological aspects in the antiphospholipid syndrome. (2003) (62)
The catastrophic antiphospholipid (Asherson's) syndrome in 2004--a review. (2005) (62)
Pulmonary hypertension in systemic lupus erythematosus: a report of three cases. (1986) (61)
Myocardial infarction in a young man with systemic lupus erythematosus, deep vein thrombosis, and antibodies to phospholipid. (1986) (60)
The physiopathology of the catastrophic antiphospholipid (Asherson's) syndrome: compelling evidence. (2009) (60)
Clinicopathologic correlations of theantiphospholipid syndrome (1995) (60)
Catastrophic antiphospholipid syndrome: proposed guidelines for diagnosis and treatment. (2002) (59)
Hypertension, renal artery stenosis and the "primary" antiphospholipid syndrome. (1991) (59)
Catastrophic antiphospholipid syndrome: remission following leg amputation in 2 cases. (2001) (59)
Intestinal involvement secondary to the antiphospholipid syndrome (APS): clinical and immunologic characteristics of 97 patients: comparison of classic and catastrophic APS. (2007) (59)
Morbidity and mortality in the catastrophic antiphospholipid syndrome: pathophysiology, causes of death, and prognostic factors. (2008) (59)
Thrombotic manifestations of the antiphospholipid syndrome in patients with malignancies (2006) (59)
Antiphospholipid antibodies, malignancies and paraproteinemias. (2000) (56)
Primary idiopathic pulmonary hypertension complicated by pulmonary arterial thrombosis. Association with antiphospholipid antibodies. (1992) (55)
Antiphospholipid antibodies--autoantibodies with a difference. (1988) (55)
Diagnostic and therapeutic problems in two patients with antiphospholipid antibodies, heart valve lesions, and transient ischaemic attacks. (1988) (53)
Disseminated intravascular coagulation, antiphospholipid antibodies, and ischaemic necrosis of extremities. (1987) (53)
Urticarial vasculitis in a connective tissue disease clinic: patterns, presentations, and treatment. (1991) (51)
Short term effects of intravenous pulses of cyclophosphamide in the treatment of connective tissue disease crisis. (1992) (51)
Hughes syndrome: antiphospholipid antibodies move closer to thrombosis in 1994. (1995) (51)
Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics. (2005) (50)
Bilateral adrenal infarction, hypoadrenalism and splinter haemorrhages in the 'primary' antiphospholipid syndrome. (1992) (50)
Pathophysiology of the catastrophic antiphospholipid syndrome (CAPS) (2000) (50)
Adrenal involvement in the antiphospholipid syndrome (2003) (49)
Antibodies to endothelial cells in dermatomyositis: association with interstitial lung disease. (1991) (49)
Pulmonary thromboembolism associated with procainamide induced lupus syndrome and anticardiolipin antibodies. (1989) (47)
Amputation of digits or limbs in patients with antiphospholipid syndrome. (2008) (47)
Ear, nose, and throat symptoms in subacute Wegener's granulomatosis. (1989) (47)
Complications of oral contraceptives and antiphospholipid antibodies: reply to the letter by Bruneau et al. (1988) (47)
Phospholipid-Binding Antibodies (1991) (47)
Microangiopathic antiphospholipid-associated syndromes revisited new concepts relating to antiphospholipid antibodies and syndromes. (2007) (45)
Antiphospholipid antibodies and HLA associations in primary Sjögren's syndrome. (1992) (45)
The catastrophic antiphospholipid (Asherson's) syndrome. (2008) (43)
Antiphospholipid syndrome: linking many specialties. (1989) (43)
Renal vein thrombosis in systemic lupus erythematosus: association with the "lupus anticoagulant". (1984) (43)
Systemic lupus erythematosus, antiphospholipid antibodies, chorea, and oral contraceptives. (1986) (41)
Pulmonary hypertension and systemic lupus erythematosus. (1986) (41)
The catastrophic antiphospholipid (Asherson's) syndrome and malignancies. (2006) (41)
Budd Chiari syndrome, visceral arterial occlusions, recurrent fetal loss and the "lupus anticoagulant" in systemic lupus erythematosus. (1989) (40)
Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment. (2008) (39)
HLA-DP genotyping in patients with systemic lupus erythematosus: correlations with autoantibody subsets. (1992) (39)
Is there a microangiopathic antiphospholipid syndrome? (2006) (39)
The hepatic complications of the antiphospholipid antibodies. (1991) (37)
Ear, nose, and throat symptoms in subacute Wegener's granulomatosis. (1989) (37)
The normocomplementemic urticarial vasculitis syndrome‐report of a case and response to colchicine (1991) (37)
Adult onset Still’s disease: response to Enbrel (2002) (36)
Anticardiolipin antibodies in a patient with Crohn's disease and thrombosis. (1992) (36)
Antiphospholipid antibodies and chorea. (1988) (34)
Aortic occlusion in systemic lupus erythematosus associated with antiphospholipid antibodies. (1987) (33)
Nonthrombotic manifestations of the antiphospholipid syndrome: away from thrombosis? (2006) (33)
Skin nodules and macules resembling vasculitis in the antiphospholipid syndrome—a report of two cases (1992) (33)
Antiphospholipid syndrome. (1996) (33)
Immunological Studies in Arteritis of the Aorta and Great Vessels* (1968) (32)
Postpartum bilateral renal vein thrombosis in the primary antiphospholipid syndrome. (1993) (32)
Review: Multiorgan Thrombotic Disorders in Systemic Lupus Erythematosus: A Common Link? (1992) (31)
Milestones in the Antiphospholipid Syndrome (2002) (31)
ARTERITIS OF THE AORTA AND ITS MAJOR BRANCHES. (1964) (30)
Intracardiac thrombus in systemic lupus erythematosus associated with lupus anticoagulant. (1988) (30)
The primary, secondary, catastrophic, and seronegative variants of the antiphospholipid syndrome: a personal history long in the making. (2008) (30)
Latent, incomplete or lupus at all? (1991) (30)
Anticardiolipin Antibodies in Migraine (1991) (29)
The antiphospholipid syndrome: multiple faces beyond the classical presentation. (2003) (29)
Human immunodeficiency virus infection, antiphospholipid antibodies, and the antiphospholipid syndrome. (2003) (29)
Autoantibodies in systemic lupus erythematosus and urticarial vasculitis. (1995) (28)
Antiphospholipid antibodies and the kidney. (1993) (27)
Myocardial infarction in systemic lupus erythematosus and "lupus-like" disease. (1986) (27)
Arterial occlusion causing large bowel infarction — a reflection of clotting diathesis in SLE (2005) (27)
Diffuse alveolar hemorrhage: a nonthrombotic antiphospholipid lung syndrome? (2005) (27)
Aortic arch syndrome associated with anticardiolipin antibodies and the lupus anticoagulant: comment on Ferrante paper. (1985) (27)
The HELLP syndrome, antiphospholipid antibodies, and syndromes (2007) (27)
Lupus psychosis: differentiation from the steroid-induced state. (1993) (27)
The expanding spectrum of Libman Sacks endocarditis: the role of antiphospholipid antibodies. (1989) (26)
Recurrent alveolar hemorrhage and pulmonary capillaritis in the "primary" antiphospholipid syndrome. (2001) (26)
Catastrophic antiphospholipid syndrome (2003) (25)
Renal infarction associated with anti-phospholipid antibodies in systemic lupus erythematosus and "lupus-like" disease. (1988) (25)
Multiple venous and arterial thromboses associated with the lupus anticoagulant and antibodies to cardiolipin in the absence of SLE (2004) (25)
Catastrophic antiphospholipid (Asherson's) syndrome. (2006) (25)
Systemic lupus erythematosus and lymphoma: association with antiphospholipid syndrome. (1991) (25)
Pulmonary Hypertension, Antiphospholipid Antibodies, and Syndromes (2007) (25)
Clinicopathologic correlations of the antiphospholipid syndrome. (1995) (25)
Catastrophic Antiphospholipid Syndrome (2007) (24)
High titres of IgM-antiphospholipid antibodies are unrelated to pathogenicity in patients with non-Hodgkin’s lymphoma (2006) (24)
Rheumatoid arthritis and pulmonary hypertension. A report of three cases. (1985) (23)
The role of malignancies in patients with catastrophic anti-phospholipid (Asherson’s) syndrome (2007) (23)
Vascular reactivity and pulmonary hypertension in systemic sclerosis. (1983) (23)
Prevalence and clinical correlates of anti‐phospholipid antibodies in South Africans with systemic lupus erythematosus (2006) (22)
Subungual splinter haemorrhages: a new sign of the antiphospholipid coagulopathy? (1990) (21)
Handbook of Systemic Autoimmune Diseases (2022) (21)
Management of retinal vein occlusion (1988) (21)
ADDISON'S DISEASE AND PRIMARY ANTIPHOSPHOLIPID SYNDROME (1989) (21)
Peripheral Vascular Occlusions Leading to Gangrene and Amputations in Antiphospholipid Antibody Positive Patients (2007) (20)
Distal aortitis complicating Reiter's syndrome. (1984) (19)
Efficacy of intravenous immunoglobulin treatment in lupus erythematosus chorea (2007) (19)
Dramatic response of severe headaches to anticoagulation in a patient with antiphospholipid syndrome. (2007) (19)
Absence of antibodies to cardiolipin in patients with Huntington's chorea, Sydenhams chorea and acute rheumatic fever. (1988) (18)
Malignant lymphoma in systemic rheumatic diseases. A report of five cases. (1991) (18)
Antiphospholipid antibodies associated with retinal vascular disease. (1990) (18)
Multiple autoimmune diseases in a young woman: tuberculosis and splenectomy as possible triggering factors? Another example of the "mosaic" of autoimmunity. (2008) (18)
Catastrophic antiphospholipid syndrome. (2006) (18)
Ankylosing spondylitis and an aortic arch syndrome. (1984) (17)
Anti-DNA antibodies in the primary antiphospholipid syndrome (PAPS) (1993) (17)
Infective endocarditis, rheumatoid factor, and anticardiolipin antibodies. (1990) (17)
The catastrophic antiphospholipid syndrome: a review of pathogenesis, clinical features and treatment. (2000) (17)
Intravenous immunoglobulin in pregnancies complicated by the antiphospholipid syndrome: what is its role? (2001) (17)
Abnormalities of development associated with hypothalamic calcification after tuberculous meningitis. (1965) (17)
Recurrent otitis media and pulmonary infiltrates as presenting features in Wegener's granulomatosis. (1988) (17)
Ehlers-Danlos syndrome type IV in a young man. (2006) (17)
Current concepts of neuropsychiatric systemic lupus erythematosus (NP-SLE). (1993) (16)
An unusually complicated case of primary Sjögren's syndrome: development of transient "lupus-type" autoantibodies following silicone implant rejection. (2004) (16)
The clinical significance of IgA antiphospholipid antibodies. (2001) (16)
Anticardiolipin and antinuclear antibodies in discoid lupus erythematosus‐their clinical significance (1988) (15)
The progressive systemic sclerosis/systemic lupus overlap: an unusual clinical progression. (1991) (15)
Pulmonary hypertension and chronic cutaneous lupus erythematosus: association with the lupus anticoagulant. (1985) (14)
Complement factor 2 deficiency: a clinical and serological family study. (1992) (13)
Acute respiratory distress syndrome and other unusual manifestations of the catastrophic antiphospholipid (Asherson's) syndrome. (2004) (13)
Hypertrophic cardiomyopathy in systemic lupus erythematosus and "lupus-like" disease. Chance association? A report of 2 cases. (1992) (13)
The significance of antibodies to DNA in the primary antiphospholipid syndrome. (1994) (13)
Hypertension and the antiphospholipid antibodies. (1993) (13)
Systemic lupus erythematosus, pulmonary hypertension and adult respiratory distress syndrome (ARDS). (1988) (13)
Recurrent pulmonary thromboembolism in a patient with systemic lupus erythematosus and HIV-1 infection associated with the presence of antibodies to prothrombin: a case report. (2005) (12)
ANTIPHOSPHOLIPID ANTIBODIES AND THROMBOSIS (1988) (12)
The use of botulinum toxin-A in the treatment of patients with fibromyalgia. (2001) (12)
Thrombotic microangiopathic antiphospholipid syndromes: a continuum of conditions? (2006) (12)
Vascular Manifestations of Systemic Autoimmune Diseases (2001) (12)
Sjögren's syndrome and fibrosing alveolitis complicated by pulmonary lymphoma. (1987) (11)
Pulmonary hypertension in Sjögren's syndrome. (1988) (11)
Antiphospholipid antibodies--middle aged but robust. (1994) (11)
Catastrophic antiphospholipid syndrome. (2000) (11)
Adrenal insufficiency in the antiphospholipid-antibody syndrome. (1996) (11)
Renal, Hepatic and other Intraabdominal Manifestations in the Antiphospholipid Syndrome (2002) (10)
A "primary" antiphospholipid syndrome? (1993) (10)
Recurrent life-threatening thromboembolism and catastrophic antiphospholipid syndrome in a patient despite sufficient oral anticoagulation (2004) (10)
Rheumatoid arthritis: clinical guideline 2003. (2003) (10)
Possible mechanisms of action of the antiphospholipid binding antibodies. (1989) (10)
Sneddon's syndrome (1989) (10)
A case of adult-onset Satoyoshi syndrome with gastric ulceration and eosinophilic enteritis (2008) (10)
Immunological studies in 'primary' idiopathic pulmonary hypertension. (1984) (9)
Antiphospholipid antibodies, valvular heart disease and systemic lupus erythematosus. (1989) (9)
Cerebrovascular disease and systemic lupus erythematosus (1987) (8)
Cryoglobulins, anticardiolipin antibodies and livedo reticularis. (1992) (8)
Encephalopathy, deafness and blindness in young women: a distinct retinocochleocerebral arteriolopathy? (1989) (8)
Antiphospholipid syndrome nephropathy in different scenarios. (2008) (7)
Multiorgan failure due to rapid occlusive vascular disease in antiphospholipid syndrome: the ‘catastrophic’ antiphospholipid syndrome (2004) (7)
SLE and the antiphospholipid antibody syndrome. (1993) (7)
Systemic lupus erythematosus complicated by tricuspid stenosis and regurgitation: successful treatment by valve transplantation. (1992) (7)
Antiphospholipid antibodies: a review. (1984) (7)
Radial artery occlusion in primary antiphospholipid syndrome after aortic valve replacement. (1995) (7)
Recurrent deep vein thrombosis, thromboembolic pulmonary hypertension and the 'primary' antiphospholipid syndrome. (1989) (7)
Catastrophic antiphospholipid (Asherson's) syndrome and genetic thrombophilic disorders in obstetrics. (2006) (7)
Antiphospholipid antibodies and the antiphospholipid syndrome. (1993) (7)
Sjøgren's Syndrome (1973) (7)
“Primary” antiphospholipid syndrome evolving into Waldenstrom’s macroglobulinaemia: a case report (2006) (7)
Sneddon's and the primary antiphospholipid syndrome: Confusion clarified. (1993) (7)
Stroke in patients with isolated IgM anticardiolipin antibody. (1994) (6)
Recurrent deep vein thrombosis, ovarian carcinoma and antibodies to mitochondria M5 in a patient with asymptomatic primary "plus" antiphospholipid syndrome: an unusual combination. (2007) (6)
Polymyositis complicating D-penicillamine treatment. (1991) (6)
Pulmonary hypertension in systemic lupus erythematosus. (1990) (6)
Pulmonary hypertension in hydralazine induced systemic lupus erythematosus: association with C4 null allele. (1986) (6)
Sex hormone modulation in systemic lupus erythematosus: still a therapeutic option? (1991) (6)
Urticarial vasculitis and syndromes in association with connective tissue diseases. (1991) (6)
Lupus, thrombotic thrombocytopenic purpura, and antiphospholipid antibodies (1989) (6)
Vascular occlusions in a patient with low positive antiphospholipid antibodies and subsequent development of breast carcinoma: a diagnostic dilemma (2007) (6)
Partial HELLP syndrome in pregnancy complicated by recurrent deep vein thromboses and palmar skin lesions in a patient with prothrombin gene 20210a mutation and antiphospholipid antibodies: an unusual case (2008) (6)
Multiple small-vessel occlusions in systemic lupus erythematosus. (1989) (5)
The antigenic significance and methods of detection of the anti-neutrophil cytoplasmic autoantibodies (ANCA). (1992) (5)
Antiphospholipid Antibodies and Malignancies (2002) (5)
The Antiphospholipid Syndrome: History, Definition, Classification, and Differential Diagnosis (2018) (5)
Probable antiphospholipid syndrome with recanalization of occluded blood vessels mimicking proliferative vasculopathy. (1994) (5)
Vocal cord paralysis in systemic lupus erythematosus complicated by pulmonary hypertension. (1985) (5)
Systemic Lupus Erythematosus and Related Disorders (1988) (5)
‘Primary’, ‘Secondary’, ‘Seronegative’, ‘Catastrophic’ and other Subsets of the Antiphospholipid Syndrome (2002) (5)
Prostacyclin in systemic lupus and anticardiolipin syndrome. (1987) (5)
Anticentromere antibody and pulmonary hypertension. (1984) (4)
Urticarial Vasculitis, IgA deficiency and C1 esterase inhibitor deficiency in the presence of an IgG monoclonal gammopathy—a case report (1992) (4)
Dermatologic aspects of Antiphospholipid Antibody Syndrome (2006) (4)
Primary pulmonary arterial hypertension and the systemic autoimmune diseases. (2006) (4)
Chapter 1 History, Classification, and Subsets of the Antiphospholipid Syndrome (2009) (4)
Anticardiolipin antibody negative occlusive vascular retinopathy in systemic lupus erythematosus. (1990) (4)
Annular, semicircular lipoatrophy of the thighs associated with incomplete "CREST" syndrome: Raynaud's, telangiectasias, and esophageal dysmotility. (2003) (3)
Vascular disease and thrombosis: relationship to the antiphospholipid antibodies. (1992) (3)
Comprar Digestive Involvement in Systemic Autoimmune Diseases Volume 8 | Ronald Asherson | 9780444531681 | Elsevier Science (2008) (3)
Atypical lupus with special reference to ANA negative lupus and lupus subsets. (1985) (3)
Methotrexate in systemic lupus erythematosus. (1997) (3)
Anticardiolipin antibodies, livedo reticularis, and cerebrovascular accidents in SLE. (1988) (3)
Antiphospholipid antibodies and "syndromes": many questions and few answers. (1990) (3)
Antiphospholipid antibodies, lupus-like disease and the “primary” antiphospholipid syndrome (1989) (3)
Pulmonary Involvement in the Antiphospholipid Syndrome (2004) (3)
Hypocomplementaemic urticarial vasculitis, angio-oedema and 'lupus-like' disease: association with C4B null allele. (1987) (3)
Proposed Guidelines for Diagnosis and Treatment (2002) (2)
Catastrophic Antiphospholipid Syndrome: Lessons from the “CAPS Registry” (2007) (2)
ANTIPHOSPHOLIPID ANTIBODIES AND THE HEART. REPLY (1992) (2)
On the catastrophic antiphospholipid syndrome. A comment on the editorial by Alarcón-Segovia. (1994) (2)
The importance of antiphospholipid antibodies. (1990) (2)
Antiphospholipid Antibodies and Vasculitis (2002) (2)
Severe hemolytic uremia syndrome and antiphospholipid antibodies following bowel infection in the absence of major vascular occlusions: an example of MAPS? (2008) (2)
Vascular Manifestations in the Antiphospholipid Syndrome (2001) (2)
Problems in the Rheumatic Diseases (1988) (1)
Sneddon's syndrome and primary anti‐phospholipid syndrome (PAPS) (1990) (1)
Antiphospholipid antibodies and fetal loss. (1992) (1)
Endocrine Manifestations in the Antiphospholipid Syndrome (2002) (1)
Chapter 10 – Antiphospholipid Antibodies and Malignancies (2000) (1)
Problems in the Rheumatic Diseases: Lessons from Patients (1988) (1)
Antiphospholipid antibodies — selected topics (1989) (1)
Catastrophic antiphospholipid syndrome: therapeutic developments (2007) (1)
Antiphospholipid syndrome : Connective tissue diseases and the skin (1993) (1)
Juvenile rheumatoid arthritis in two siblings: co-existence with polyarteritis nodosa in one parent. (1984) (1)
Antineutrophil Cytoplasmic Antibodies (2001) (1)
[Antiphospholipid syndrome: an evolving entity]. (1991) (1)
Pulmonary Manifestations in the Antiphospholipid Syndrome (2018) (1)
Syndrome catastrophique des antiphospholipides: 50 observations (1997) (0)
Sjogren's syndrome andfibrosing alveolitis complicated bypulmonary lymphoma (1987) (0)
Antiphospholipid antibodies in South Africa blacks with connective tissue diseases--more evidence for an 'aPL-negative coagulopathy'? (1993) (0)
Anti-VDRL antibodies by ELISA in cerebrospinal fluid and its value in the differential diagnosis of abnormalities of the cerebrospinal fluid. (1992) (0)
Primary antiphospholipid syndrome. (1990) (0)
COMMENT ON : THE ROLE OF MICROVASCULOPATHY IN THE CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME. AUTHORS' REPLY (1998) (0)
Revealing the evolution of the term APS and its commonalities with other microangiopathic disorders (2007) (0)
Predictive Value of the Anticardiolipin Antibody for Thrombosis, Foetal Loss and Thrombocytopaenia (1986) (0)
THE ANTIPHOSPHOLIPID SYNDROME. II: AUTOIMMUNE (2003) (0)
[Variants of antiphospholipid syndrome: some new conceptions?]. (2008) (0)
“Primary”, “Secondary”, “Catastrophic”, and Other Variants of the Antiphospholipid Syndrome (2018) (0)
Antiphospholipid antibodies: ariskfactor for occlusive ocular vascular disease insystemic lupus erythematosus andthe'primary' antiphospholipid (1989) (0)
Cerebral Thrombosis and Other Neurological Manifestations in the Antiphospholipid Syndrome (2018) (0)
Drug Treatment of Stroke in Patients with Antiphospholipid Antibodies (1997) (0)
[Sneddon syndrome and antiphospholipid antibodies]. (1988) (0)
Anti-Phospholipid Antibodies: Clinical Complications Reported in Medical Literature (2020) (0)
Comment on the article by Stafford-Brady et al. (1989) (0)
Standard abbreviations for antiphospholipid antibodies. (1989) (0)
Vascular Manigestations in Necrotizing and Granulomatous Vasculitides (2001) (0)
Salazopyrin EN in rheumatoid arthritis (1987) (0)
“Primary” Anti-Phospholipid Syndrome (2020) (0)
The preventative role of heparin in antiphospholipid antibody-induced fetal loss (2006) (0)
Microstomia does not necessarily mean scleroderma. (1996) (0)
The catastrophic antiphospholipid syndrome and the microangiopathic antiphospholipid syndrome (2007) (0)
transient " lupus-type " autoantibodies following silicone implant rejection . An unusually complicated case of primary Sjögren ' s syndrome : development of (2008) (0)
Aortic occlusion insystemic lupuserythematosus associated withantiphospholipid antibodies (1987) (0)
Antiphospholipid syndrome--an unusual presentation. (1993) (0)
More about : antiphospholipid antibodies and syndromes : relevance for the GP (2008) (0)
Letter: Drugs in obesity. (1975) (0)
Scientific papers Antiphospholipid antibodies : a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the ' primary ' antiphospholipid syndrome (2004) (0)
Rheumatology. (1991) (0)
Antiphospholipid antibodies: guidelines for determination. (1997) (0)
Chapter 13 Antiphospholipid Antibodies and Vasculitis (2009) (0)
Antiphospholipid antibodies and HLA associations in primary S jogren ' s syndrome (0)
[Diabetic cheirarthropathy simulating sclerodermia]. (1990) (0)
Pulmonary hypertension in the connective tissue disease pathogenesis, clinical features and therapeutic options in 2006 (2007) (0)
In its classic presentation, the antiphospholipid syndrome manifests a combination of venous or arterial thrombosis and fetal loss, accompanied by elevations of antibodies directed toward negatively charged phospholipids, as measured by anticardiolipin antibody assays and/or positive lupus anticoag- (0)
The Journal of Rheumatology Volume 33 , no . 6 thrombosis ? Nonthrombotic manifestations of the antiphospholipid syndrome : away from (2006) (0)
Ear, nose, and throat symptoms in subacute Wegener's granulomatosis: Authors' reply (1989) (0)
Microangiopathic antiphospholipid-associated syndromes revisited new (2007) (0)
Occlusive retinal vascular disease in two patients. (1989) (0)
Antiphospholipid antibodies: The clinic and the laboratory (1993) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Ronald A. Asherson?

Ronald A. Asherson is affiliated with the following schools:

Ronald A. Asherson's Academic­Influence.com Rankings

Why Is Ronald A. Asherson Influential?

Ronald A. Asherson's Published Works

Published Works

What Schools Are Affiliated With Ronald A. Asherson?

Ronald A. Asherson's AcademicInfluence.com Rankings